Legal Representation
Attorney
Andrew J. Gray IV
USPTO Deadlines
Application History
31 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 12, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
May 27, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Oct 24, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Sep 10, 2023 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
Jul 18, 2023 | CHPB | I | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | Loading... |
Jul 17, 2023 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
Jul 5, 2023 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
May 16, 2023 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
May 2, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 2, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 12, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 25, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 24, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Feb 24, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Feb 24, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Jan 31, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 31, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 31, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 3, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 3, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Aug 3, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 6, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 5, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 5, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 2, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jan 2, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jan 2, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Dec 26, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 4, 2021 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Aug 3, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 1, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Electronic data storage, namely, storage of genetic data and scientific analysis services performed thereto relating to diagnoses and treatment of genetic disorders and for eyecare
Class 044
DNA screening for medical diagnostic purposes relating to genetic disorders and for eyecare; medical information services, namely, providing risk scores and treatment and diagnostic information associated with genes, variants, and mutations associated with eye disease
Additional Information
Design Mark
The mark consists of the following: the stylized wording "AVAGEN" in blue, above the stylized wording "THE GENETIC EYE TEST" in blue, and to the right of a partial circle design shaded in orange, with three white circles in the top of the partial circle and with shaded orange dots, some connected with orange lines, in-between the ends of the partial circle. Other than as specified, the color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
Color Claim
The color(s) blue, orange and white is/are claimed as a feature of the mark.
Pseudo Mark
AVA GENETIC THE GENETIC EYE TEST
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THE GENETIC EYE TEST"